Inflammatory Biomarkers of Low Back Pain and Disc Degeneration: a Review

Overview

Journal Ann N Y Acad Sci

Specialty Science

Date 2017 Dec 22

PMID 29265416

Citations 171

Authors

Aysha N Khan

Hayley E Jacobsen

Jansher Khan

Christopher G Filippi

Mitchell Levine

Ronald A Lehman Jr

K Daniel Riew

Lawrence G Lenke

Nadeen O Chahine

Affiliations

Soon will be listed here.

Abstract

Biomarkers are biological characteristics that can be used to indicate health or disease. This paper reviews studies on biomarkers of low back pain (LBP) in human subjects. LBP is the leading cause of disability, caused by various spine-related disorders, including intervertebral disc degeneration, disc herniation, spinal stenosis, and facet arthritis. The focus of these studies is inflammatory mediators, because inflammation contributes to the pathogenesis of disc degeneration and associated pain mechanisms. Increasingly, studies suggest that the presence of inflammatory mediators can be measured systemically in the blood. These biomarkers may serve as novel tools for directing patient care. Currently, patient response to treatment is unpredictable with a significant rate of recurrence, and, while surgical treatments may provide anatomical correction and pain relief, they are invasive and costly. The review covers studies performed on populations with specific diagnoses and undefined origins of LBP. Since the natural history of LBP is progressive, the temporal nature of studies is categorized by duration of symptomology/disease. Related studies on changes in biomarkers with treatment are also reviewed. Ultimately, diagnostic biomarkers of LBP and spinal degeneration have the potential to shepherd an era of individualized spine medicine for personalized therapeutics in the treatment of LBP.

Citing Articles

Piezo1 promotes intervertebral disc degeneration through the Ca/F-actin/Yap signaling axis.

Peng F, Sun M, Jing X, Chen F, Cao T, Li Z Mol Med. 2025; 31(1):90.

PMID: 40057686 PMC: 11889814. DOI: 10.1186/s10020-025-01147-z.

Efficacy of Naringenin against aging and degeneration of nucleus pulposus cells through IGFBP3 inhibition.

Tang X, Zhong J, Luo H, Zhou F, Wang L, Lin S Sci Rep. 2025; 15(1):6780.

PMID: 40000729 PMC: 11861589. DOI: 10.1038/s41598-025-90909-0.

The mTOR pathway is involved in the process of platelet-rich plasma improving intervertebral disc degeneration.

Luan J, Wang Q, Zheng W, He Y Iran J Basic Med Sci. 2025; 28(3):393-400.

PMID: 39906617 PMC: 11790196. DOI: 10.22038/ijbms.2024.79218.17163.

Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles.

Chen S, Dou Y, Zhang Y, Sun X, Liu X, Yang Q J Orthop Translat. 2025; 50:44-55.

PMID: 39868351 PMC: 11761297. DOI: 10.1016/j.jot.2024.09.014.

Gastrodin Alleviates Lumbar Intervertebral Disc Degeneration by Suppressing the NF-κB and MAPK Pathways.

Hu H, Xie T Cell Biochem Biophys. 2025; .

PMID: 39821825 DOI: 10.1007/s12013-024-01612-2.

References

Luchting B, Rachinger-Adam B, Zeitler J, Egenberger L, Mohnle P, Kreth S . Disrupted TH17/Treg balance in patients with chronic low back pain. PLoS One. 2014; 9(8):e104883. PMC: 4133258. DOI: 10.1371/journal.pone.0104883. View

. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N . Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J. 2012; 21(10):2079-84. PMC: 3463692. DOI: 10.1007/s00586-012-2183-5. View

Southern E, Fye M, Panjabi M, Patel T, Cholewicki J . Disc degeneration: a human cadaveric study correlating magnetic resonance imaging and quantitative discomanometry. Spine (Phila Pa 1976). 2000; 25(17):2171-5. DOI: 10.1097/00007632-200009010-00005. View

Alvarez J, Hardy Jr R . Lumbar spine stenosis: a common cause of back and leg pain. Am Fam Physician. 1998; 57(8):1825-34, 1839-40. View

Cassidy J, Carroll L, Cote P . The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976). 1998; 23(17):1860-6; discussion 1867. DOI: 10.1097/00007632-199809010-00012. View

Auerbach J, Johannessen W, Borthakur A, Wheaton A, Dolinskas C, Balderston R . In vivo quantification of human lumbar disc degeneration using T(1rho)-weighted magnetic resonance imaging. Eur Spine J. 2006; 15 Suppl 3:S338-44. PMC: 2335378. DOI: 10.1007/s00586-006-0083-2. View

Hayes A, Benjamin M, Ralphs J . Extracellular matrix in development of the intervertebral disc. Matrix Biol. 2001; 20(2):107-21. DOI: 10.1016/s0945-053x(01)00125-1. View

Wang K, Bao J, Yang S, Hong X, Liu L, Xie X . A cohort study comparing the serum levels of pro- or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects. Eur Spine J. 2015; 25(5):1428-1434. DOI: 10.1007/s00586-015-4349-4. View

10.

Taylor T, Melrose J, Burkhardt D, Ghosh P, Claes L, Kettler A . Spinal biomechanics and aging are major determinants of the proteoglycan metabolism of intervertebral disc cells. Spine (Phila Pa 1976). 2001; 25(23):3014-20. DOI: 10.1097/00007632-200012010-00008. View

11.

Andrade P, Hoogland G, Del Rosario J, Steinbusch H, Visser-Vandewalle V, Daemen M . Tumor necrosis factor-α inhibitors alleviation of experimentally induced neuropathic pain is associated with modulation of TNF receptor expression. J Neurosci Res. 2014; 92(11):1490-8. DOI: 10.1002/jnr.23432. View

12.

Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen T, Maclean D, Pedersen B . Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J Physiol. 1997; 499 ( Pt 3):833-41. PMC: 1159298. DOI: 10.1113/jphysiol.1997.sp021972. View

13.

Qaseem A, Wilt T, McLean R, Forciea M, Denberg T, Barry M . Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017; 166(7):514-530. DOI: 10.7326/M16-2367. View

14.

Zu B, Pan H, Zhang X, Yin Z . Serum Levels of the Inflammatory Cytokines in Patients with Lumbar Radicular Pain Due to Disc Herniation. Asian Spine J. 2016; 10(5):843-849. PMC: 5081318. DOI: 10.4184/asj.2016.10.5.843. View

15.

Deyo R, Mirza S, Martin B . Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976). 2006; 31(23):2724-7. DOI: 10.1097/01.brs.0000244618.06877.cd. View

16.

Weber K, Alipui D, Sison C, Bloom O, Quraishi S, Overby M . Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases. Arthritis Res Ther. 2016; 18:3. PMC: 4718017. DOI: 10.1186/s13075-015-0887-8. View

17.

Xie P, Liu B, Chen R, Yang B, Dong J, Rong L . Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation. Biomed Rep. 2014; 2(5):693-698. PMC: 4106592. DOI: 10.3892/br.2014.295. View

18.

Park C, Lee S . Prognostic usefulness of high sensitivity C-reactive protein for transforaminal epidural steroid injection in patients with radicular pain. Pain Med. 2011; 12(2):219-23. DOI: 10.1111/j.1526-4637.2010.01039.x. View

19.

Wuertz K, Haglund L . Inflammatory mediators in intervertebral disk degeneration and discogenic pain. Global Spine J. 2014; 3(3):175-84. PMC: 3854585. DOI: 10.1055/s-0033-1347299. View

20.

Chou R . In the clinic. Low back pain. Ann Intern Med. 2014; 160(11):ITC6-1. DOI: 10.7326/0003-4819-160-11-201406030-01006. View